オプションチェーンは、Relay Therapeuticsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Relay Therapeuticsの市場センチメントを評価します。.

Relay Therapeutics (NASDAQ:RLAY) 株価情報, オプションチェーン

RELAY THERAPEUTICS INC

Relay Therapeutics

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Relay Therapeutics Inc

WIIM

OGEN

Oragenics shares are trading lower after the company announced a 1-for-30 reverse stock split.

MLAB

Mesa Laboratories shares are trading lower following Q4 reported financial results.

News

Rumors

Trading Ideas

ARVN

Watching Arvinas; Traders Circulate Zacks Under $10 Newsletter Picks Stock

IMCC

IM Cannabis shares are trading higher after the company announced it will voluntarily delist from the Canadian Securities Exchange.

VNET

VNET Group shares are trading lower after the company reported worse-than-expected Q1 financial results.

CLGN

CollPlant Biotechnologies shares are trading higher. The company reported Q1 financial results.

Ambarella (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMBA#NASDAQ">AMBA</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-05-29. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Ambarella will report an earnings per share (EPS) of $0.04.
The market awaits Ambarella's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Historical Earnings Performance</h3>
During the last quarter, the company reported an EPS beat by $0.13, leading to a 17.13% drop in the share price on the subsequent day.
Here's a look at Ambarella's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2025</th>
<th>Q3 2025</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>0.04</td>
<td>-0.19</td>
<td>-0.31</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.11</td>
<td>0.11</td>
<td>-0.13</td>
<td>-0.26</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-17.0%</td>
<td>6.0%</td>
<td>11.0%</td>
<td>21.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1748444550_0.png" alt="eps graph" />
<h3>Market Performance of Ambarella's Stock</h3>
Shares of Ambarella were trading at $62.48 as of May 27. Over the last 52-week period, shares are up 28.42%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Analyst Views on Ambarella</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Ambarella.
With 5 analyst ratings, Ambarella has a consensus rating of Buy. The average one-year price target is $94.0, indicating a potential 50.45% upside.
<h3>Analyzing Analyst Ratings Among Peers</h3>
The analysis below examines the analyst ratings and average 1-year price targets of Power Integrations, Synaptics and Diodes, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Power Integrations, with an average 1-year price target of $72.5, suggesting a potential 16.04% upside.</li>
<li>Analysts currently favor an Buy trajectory for Synaptics, with an average 1-year price target of $92.5, suggesting a potential 48.05% upside.</li>
<li>Analysts currently favor an Buy trajectory for Diodes, with an average 1-year price target of $55.0, suggesting a potential 11.97% downside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
The peer analysis summary presents essential metrics for Power Integrations, Synaptics and Diodes, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ambarella</td>
<td>Buy</td>
<td>62.77%</td>
<td>$50.38M</td>
<td>-3.63%</td>
</tr>
<tr>
<td>Power Integrations</td>
<td>Buy</td>
<td>15.10%</td>
<td>$58.23M</td>
<td>1.18%</td>
</tr>
<tr>
<td>Synaptics</td>
<td>Buy</td>
<td>12.35%</td>
<td>$115.80M</td>
<td>-1.58%</td>
</tr>
<tr>
<td>Diodes</td>
<td>Buy</td>
<td>9.98%</td>
<td>$104.69M</td>
<td>-0.25%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Ambarella ranks first in Revenue Growth among its peers. It ranks last in Gross Profit. It ranks last in Return on Equity.
<h3>About Ambarella</h3>
Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, security cameras, consumer cameras, and industrial and robotic applications. The company's system-on-a-chip designs, based on its proprietary technology platform, are highly configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.
<h3>Unraveling the Financial Story of Ambarella</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Ambarella's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 62.77% as of 31 January, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Ambarella's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -24.08%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Ambarella's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -3.63%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Ambarella's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -2.98%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.01, Ambarella adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/AMBA/earnings">To track all earnings releases for Ambarella visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

AMBA

A Look Ahead: Ambarella's Earnings Forecast

CRNC

Cerence Announces Strategic Partnership With Arm To Leverage Arm Kleidi To Advance Capabilities And Performance Of CaLLM Edge

Kohl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-05-29. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Kohl's will report an earnings per share (EPS) of $-0.53.
Anticipation surrounds Kohl's's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Overview of Past Earnings</h3>
During the last quarter, the company reported an EPS beat by $0.18, leading to a 5.9% drop in the share price on the subsequent day.
Here's a look at Kohl's's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.77</td>
<td>0.27</td>
<td>0.45</td>
<td>0.04</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.95</td>
<td>0.20</td>
<td>0.59</td>
<td>-0.24</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-6.0%</td>
<td>-3.0%</td>
<td>1.0%</td>
<td>7.000000000000001%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1748444541_0.png" alt="eps graph" />
<h3>Performance of Kohl's Shares</h3>
Shares of Kohl's were trading at $7.91 as of May 27. Over the last 52-week period, shares are down 62.46%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analysts' Perspectives on Kohl's</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Kohl's.
Kohl's has received a total of 21 ratings from analysts, with the consensus rating as Neutral. With an average one-year price target of $8.46, the consensus suggests a potential 6.95% upside.
<h3>Peer Ratings Comparison</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of and Kohl's, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<h3>Snapshot: Peer Analysis</h3>
In the peer analysis summary, key metrics for and Kohl's are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kohl's</td>
<td>Neutral</td>
<td>-9.39%</td>
<td>$1.92B</td>
<td>1.26%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Kohl's is positioned in the middle among its peers for consensus rating. It ranks at the bottom for revenue growth. In terms of gross profit, Kohl's is at the top among its peers. However, for return on equity, Kohl's is at the bottom compared to its peers.
<h3>Get to Know Kohl's Better</h3>
Kohl's operates about 1,150 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also has a large digital sales operation. Women's apparel is Kohl's largest category, having generated 25% of its 2024 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
<h3>Breaking Down Kohl's's Financial Performance</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining Kohl's's financials over 3 months reveals challenges. As of 31 January, 2025, the company experienced a decline of approximately -9.39% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 0.89%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 1.26%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Kohl's's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.34%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a high debt-to-equity ratio of 1.88, Kohl's faces challenges in effectively managing its debt levels, indicating potential financial strain.
<a href="https://www.benzinga.com/quote/KSS/earnings">To track all earnings releases for Kohl's visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Kohl's

Foot Locker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-05-29. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Foot Locker will report an earnings per share (EPS) of $0.41.
The market awaits Foot Locker's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Earnings History Snapshot</h3>
The company's EPS beat by $0.14 in the last quarter, leading to a 2.3% drop in the share price on the following day.
Here's a look at Foot Locker's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.72</td>
<td>0.40</td>
<td>-0.08</td>
<td>0.12</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.86</td>
<td>0.33</td>
<td>-0.05</td>
<td>0.22</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>-4.0%</td>
<td>6.0%</td>
<td>7.000000000000001%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1748444531_0.png" alt="eps graph" />
<h3>Performance of Foot Locker Shares</h3>
Shares of Foot Locker were trading at $23.9 as of May 27. Over the last 52-week period, shares are down 8.13%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analyst Insights on Foot Locker</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Foot Locker.
Analysts have provided Foot Locker with 20 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $19.95, suggesting a potential 16.53% downside.
<h3>Comparing Ratings with Competitors</h3>
The below comparison of the analyst ratings and average 1-year price targets of Buckle, American Eagle Outfitters and Victoria's Secret, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Buckle, with an average 1-year price target of $41.0, suggesting a potential 71.55% upside.</li>
<li>Analysts currently favor an Neutral trajectory for American Eagle Outfitters, with an average 1-year price target of $13.29, suggesting a potential 44.39% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Victoria's Secret, with an average 1-year price target of $24.18, suggesting a potential 1.17% upside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
In the peer analysis summary, key metrics for Buckle, American Eagle Outfitters and Victoria's Secret are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Foot Locker</td>
<td>Neutral</td>
<td>-5.70%</td>
<td>$668M</td>
<td>1.70%</td>
</tr>
<tr>
<td>Buckle</td>
<td>Neutral</td>
<td>-28.24%</td>
<td>$199.49M</td>
<td>8.10%</td>
</tr>
<tr>
<td>American Eagle Outfitters</td>
<td>Neutral</td>
<td>-4.42%</td>
<td>$599.17M</td>
<td>5.94%</td>
</tr>
<tr>
<td>Victoria's Secret</td>
<td>Neutral</td>
<td>1.10%</td>
<td>$813M</td>
<td>36.11%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Foot Locker ranks at the bottom for Revenue Growth and Gross Profit, while it is in the middle for Return on Equity.
<h3>Delving into Foot Locker's Background</h3>
Foot Locker Inc operates footwear and apparel retailer in North America, Europe, Australia, New Zealand, and Asia, and has licensed store presence in the Middle East, Europe, and Asia. The company mainly sells athletically inspired shoes and apparel. Foot Locker's merchandise comes from only a few suppliers, with Nike providing the majority. Its portfolio of brands includes Foot Locker, Kids Foot Locker, Champs Sports, WSS, and atmos. The company has omnichannel capabilities to bridge the digital world and physical stores, including order-in-store, buy online and pickup-in-store, and buy online and ship-from-store, as well as e-commerce. It has three operating segments, North America, EMEA, and Asia Pacific.
<h3>Foot Locker's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, Foot Locker faced challenges, resulting in a decline of approximately -5.7% in revenue growth as of 31 January, 2025. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Foot Locker's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 2.18%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Foot Locker's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 1.7%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Foot Locker's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.72%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 0.96, Foot Locker adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/FL/earnings">To track all earnings releases for Foot Locker visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

An Overview of Foot Locker's Earnings

Roivant Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROIV#NASDAQ">ROIV</a>) will release its quarterly earnings report on Thursday, 2025-05-29. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Roivant Sciences to report an earnings per share (EPS) of $-0.16.
The announcement from Roivant Sciences is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Earnings Track Record</h3>
In the previous earnings release, the company beat EPS by $0.04, leading to a 2.78% drop in the share price the following trading session.
Here's a look at Roivant Sciences's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2025</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.24</td>
<td>-0.26</td>
<td>-0.26</td>
<td>-0.30</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.20</td>
<td>-0.25</td>
<td>-0.17</td>
<td>-0.19</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-3.0%</td>
<td>3.0%</td>
<td>2.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1748444523_0.png" alt="eps graph" />
<h3>Roivant Sciences Share Price Analysis</h3>
Shares of Roivant Sciences were trading at $10.76 as of May 27. Over the last 52-week period, shares are up 4.04%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Observations about Roivant Sciences</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Roivant Sciences.
Analysts have provided Roivant Sciences with 2 ratings, resulting in a consensus rating of Buy. The average one-year price target stands at $18.0, suggesting a potential 67.29% upside.
<h3>Peer Ratings Comparison</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of Halozyme Therapeutics and Blueprint Medicines, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Halozyme Therapeutics, with an average 1-year price target of $60.8, suggesting a potential 465.06% upside.</li>
<li>Analysts currently favor an Buy trajectory for Blueprint Medicines, with an average 1-year price target of $129.5, suggesting a potential 1103.53% upside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
The peer analysis summary presents essential metrics for Halozyme Therapeutics and Blueprint Medicines, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Roivant Sciences</td>
<td>Buy</td>
<td>-42.05%</td>
<td>$8.76M</td>
<td>3.28%</td>
</tr>
<tr>
<td>Halozyme Therapeutics</td>
<td>Neutral</td>
<td>35.22%</td>
<td>$216.46M</td>
<td>27.92%</td>
</tr>
<tr>
<td>Blueprint Medicines</td>
<td>Buy</td>
<td>55.45%</td>
<td>$146.61M</td>
<td>0.15%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Roivant Sciences ranks at the bottom for Revenue Growth among its peers. It is at the top for Gross Profit. For Return on Equity, it is at the bottom compared to its peers.
<h3>Unveiling the Story Behind Roivant Sciences</h3>
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
<h3>Roivant Sciences: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Roivant Sciences's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately -42.05%. This indicates a decrease in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Roivant Sciences's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 1878.25%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Roivant Sciences's ROE excels beyond industry benchmarks, reaching 3.28%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Roivant Sciences's ROA excels beyond industry benchmarks, reaching 2.82%. This signifies efficient management of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.02, Roivant Sciences adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/ROIV/earnings">To track all earnings releases for Roivant Sciences visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ROIV

Roivant Sciences's Earnings Outlook

Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) is set to give its latest quarterly earnings report on Thursday, 2025-05-29. Here's what investors need to know before the announcement.
Analysts estimate that Elastic will report an earnings per share (EPS) of $0.39. 
Anticipation surrounds Elastic's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Historical Earnings Performance</h3>
During the last quarter, the company reported an EPS beat by $0.16, leading to a 14.89% increase in the share price on the subsequent day.
Here's a look at Elastic's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2025</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.47</td>
<td>0.38</td>
<td>0.25</td>
<td>0.20</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.63</td>
<td>0.59</td>
<td>0.35</td>
<td>0.21</td>
</tr>
<tr>
<td>Price Change %</td>
<td>15.0%</td>
<td>15.0%</td>
<td>-26.0%</td>
<td>12.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1748444512_0.png" alt="eps graph" />
<h3>Elastic Share Price Analysis</h3>
Shares of Elastic were trading at $92.85 as of May 27. Over the last 52-week period, shares are down 0.18%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/ESTC/earnings">To track all earnings releases for Elastic visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ESTC

Earnings Outlook For Elastic

Bath &amp; Body Works (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-05-29. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Bath &amp; Body Works will report an earnings per share (EPS) of $0.43.
Anticipation surrounds Bath &amp; Body Works's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Historical Earnings Performance</h3>
During the last quarter, the company reported an EPS beat by $0.05, leading to a 1.03% increase in the share price on the subsequent day.
Here's a look at Bath &amp; Body Works's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.04</td>
<td>0.47</td>
<td>0.36</td>
<td>0.32</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.09</td>
<td>0.49</td>
<td>0.37</td>
<td>0.38</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>-2.0%</td>
<td>-4.0%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1748444506_0.png" alt="eps graph" />
<h3>Tracking Bath &amp; Body Works's Stock Performance</h3>
Shares of Bath &amp; Body Works were trading at $30.54 as of May 27. Over the last 52-week period, shares are down 39.81%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/BBWI/earnings">To track all earnings releases for Bath &amp; Body Works visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBWI

Insights into Bath & Body Works's Upcoming Earnings

Citizens (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIA#NYSE">CIA</a>) is preparing to release its quarterly earnings on Thursday, 2025-03-13. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Citizens to report an earnings per share (EPS) of $0.09.
Citizens bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Overview of Past Earnings</h3>
During the last quarter, the company reported an EPS missed by $0.03, leading to a 5.38% drop in the share price on the subsequent day.
Here's a look at Citizens's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.09</td>
<td>0.08</td>
<td>0.06</td>
<td></td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.07</td>
<td>0.05</td>
<td>0.08</td>
<td>0.09</td>
</tr>
<tr>
<td>Price Change %</td>
<td>4.0%</td>
<td>-5.0%</td>
<td>2.0%</td>
<td>12.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1748444499_0.png" alt="eps graph" />
<h3>Tracking Citizens's Stock Performance</h3>
Shares of Citizens were trading at $3.67 as of May 27. Over the last 52-week period, shares are up 26.5%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/CIA/earnings">To track all earnings releases for Citizens visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Preview Of Citizens's Earnings

Disclosed on May 27, David M Wathen, Director at Franklin Electric (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FELE#NASDAQ">FELE</a>), executed a substantial insider sell as per the latest SEC filing.
What Happened: A Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000038725/000003872525000133//Archives/edgar/data/38725/000003872525000133/0000038725-25-000133-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday outlined that Wathen executed a sale of 25,000 shares of Franklin Electric with a total value of $2,167,500.
During Wednesday's morning session, Franklin Electric shares down by 0.0%, currently priced at $87.29.
<h3>Discovering Franklin Electric: A Closer Look</h3>
Franklin Electric Co Inc designs, manufactures, and distributes water and fuel pumping systems, composed of submersible motors, pumps, electronic controls, water treatment systems, and related parts and equipment. It has three segments; The Water Systems segment designs, manufactures and sells motors, pumps, drives, electronic controls, monitoring devices, and related parts and equipment for use in groundwater, water transfer, and wastewater, The Energy Systems segment designs, manufactures and sells pumps, pipe, sumps, fittings, vapor recovery components, electronic controls, monitoring devices, and related parts and equipment for use in fueling system applications and the Distribution segment sells and provides presale support and specifications to the installing contractors.
<h3>Franklin Electric's Economic Impact: An Analysis</h3>
Revenue Challenges: Franklin Electric's revenue growth over 3 months faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -1.23%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Insights into Profitability:
<ul>
<li>
Gross Margin: With a low gross margin of 36.0%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Franklin Electric's EPS reflects a decline, falling below the industry average with a current EPS of 0.67.
</li>
</ul>
Debt Management: Franklin Electric's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.17.
Understanding Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 22.79 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The P/S ratio of 2.01 is lower than the industry average, implying a discounted valuation for Franklin Electric's stock in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Franklin Electric's EV/EBITDA ratio at 13.98 suggests potential undervaluation, falling below industry averages.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Delving Into the Significance of Insider Transactions</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
In the context of legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
<h3>Understanding Crucial Transaction Codes</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000038725">Check Out The Full List Of Franklin Electric's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

FELE

Franklin Electric Director Sold $2.17M In Company Stock

A significant insider buy by GREGORY SUMME, Director at Avantor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>), was executed on May 27, and reported in the recent SEC filing.
What Happened: SUMME demonstrated confidence in Avantor by purchasing 30,000 shares, as reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001722482/000172248225000165//Archives/edgar/data/1722482/000172248225000165/0001722482-25-000165-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday. The total value of the transaction is $375,000.
In the Wednesday's morning session, Avantor's shares are currently trading at $13.24, experiencing a up of 0.68%.
<h3>Unveiling the Story Behind Avantor</h3>
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education &amp; government, and advanced technologies &amp; applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment &amp; instrumentation, Services &amp; specialty procurement, Proprietary materials &amp; consumables, and Third-party materials &amp; consumables. Materials &amp; consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
<h3>Financial Insights: Avantor</h3>
Revenue Challenges: Avantor's revenue growth over 3 months faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -5.86%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: The company faces challenges with a low gross margin of 33.82%, suggesting potential difficulties in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Avantor's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 0.09.
</li>
</ul>
Debt Management: Avantor's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.67.
Understanding Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 12.64 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: The P/S ratio of 1.34 is lower than the industry average, implying a discounted valuation for Avantor's stock in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With a below-average EV/EBITDA ratio of 8.73, Avantor presents an opportunity for value investors. This lower valuation may attract investors seeking undervalued opportunities.
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Illuminating the Importance of Insider Transactions</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Important Transaction Codes</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001722482">Check Out The Full List Of Avantor's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AVTR

GREGORY SUMME Takes a Bullish Stance: Acquires $375K In Avantor Stock

Gap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) is preparing to release its quarterly earnings on Thursday, 2025-05-29. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Gap to report an earnings per share (EPS) of $0.43.
Gap bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Earnings Track Record</h3>
Last quarter the company beat EPS by $0.16, which was followed by a 18.84% increase in the share price the next day.
Here's a look at Gap's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.38</td>
<td>0.58</td>
<td>0.40</td>
<td>0.14</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.54</td>
<td>0.72</td>
<td>0.54</td>
<td>0.41</td>
</tr>
<tr>
<td>Price Change %</td>
<td>19.0%</td>
<td>13.0%</td>
<td>-2.0%</td>
<td>28.999999999999996%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1748444490_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Gap were trading at $28.44 as of May 27. Over the last 52-week period, shares are up 25.27%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analysts' Take on Gap</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Gap.
With 18 analyst ratings, Gap has a consensus rating of Neutral. The average one-year price target is $27.61, indicating a potential 2.92% downside.
<h3>Comparing Ratings with Competitors</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of Urban Outfitters, Burlington Stores and Boot Barn Holdings, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Urban Outfitters, with an average 1-year price target of $65.32, suggesting a potential 129.68% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Burlington Stores, with an average 1-year price target of $321.64, suggesting a potential 1030.94% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Boot Barn Holdings, with an average 1-year price target of $170.0, suggesting a potential 497.75% upside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
The peer analysis summary outlines pivotal metrics for Urban Outfitters, Burlington Stores and Boot Barn Holdings, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gap</td>
<td>Neutral</td>
<td>-3.47%</td>
<td>$1.61B</td>
<td>6.44%</td>
</tr>
<tr>
<td>Urban Outfitters</td>
<td>Neutral</td>
<td>-18.74%</td>
<td>$527.68M</td>
<td>4.42%</td>
</tr>
<tr>
<td>Burlington Stores</td>
<td>Outperform</td>
<td>4.82%</td>
<td>$1.41B</td>
<td>20.72%</td>
</tr>
<tr>
<td>Boot Barn Holdings</td>
<td>Outperform</td>
<td>16.81%</td>
<td>$168.56M</td>
<td>3.38%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Gap is positioned in the middle among its peers for consensus rating. It ranks at the bottom for revenue growth. In terms of gross profit, Gap is at the top among its peers. However, for return on equity, Gap is positioned in the middle compared to its peers.
<h3>Discovering Gap: A Closer Look</h3>
Gap retails apparel, accessories, and personal-care products under the Gap, Old Navy, Banana Republic, and Athleta brands. Old Navy generates more than half of Gap's sales. The firm also operates e-commerce sites, outlet stores, and specialty stores under various Gap names. Gap operates approximately 2,500 stores in North America, Europe, and Asia and franchises about 1,000 more in Asia, Europe, Latin America, and other regions. Gap was founded in 1969 and is based in San Francisco.
<h3>Breaking Down Gap's Financial Performance</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, Gap faced challenges, resulting in a decline of approximately -3.47% in revenue growth as of 31 January, 2025. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 4.97%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Gap's ROE excels beyond industry benchmarks, reaching 6.44%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Gap's ROA stands out, surpassing industry averages. With an impressive ROA of 1.74%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Gap's debt-to-equity ratio stands notably higher than the industry average, reaching 1.68. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<a href="https://www.benzinga.com/quote/GAP/earnings">To track all earnings releases for Gap visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse of Gap's Earnings Potential

Scott Dols V, Director at OPAL Fuels (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPAL#NASDAQ">OPAL</a>), disclosed an insider purchase on May 27, based on a new SEC filing.
What Happened: In a significant move reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001842279/000162828025027982//Archives/edgar/data/1842279/000162828025027982/0001628280-25-027982-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday, V purchased 50,232 shares of OPAL Fuels, demonstrating confidence in the company's growth potential. The total value of the transaction stands at $128,749.
OPAL Fuels shares are trading up 5.11% at $3.29 at the time of this writing on Wednesday morning.
<h3>All You Need to Know About OPAL Fuels</h3>
OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.
<h3>OPAL Fuels: Financial Performance Dissected</h3>
Revenue Growth: OPAL Fuels's remarkable performance in 3 months is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 31.49%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Energy sector, the company excelled with a growth rate higher than the average among peers.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: The company excels with a remarkable gross margin of 31.34%, indicating superior cost efficiency and profitability compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): OPAL Fuels's EPS is below the industry average. The company faced challenges with a current EPS of -0.01. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: With a high debt-to-equity ratio of 5.4, OPAL Fuels faces challenges in effectively managing its debt levels, indicating potential financial strain.
In-Depth Valuation Examination:
<ul>
<li>
Price to Earnings (P/E) Ratio: A higher-than-average P/E ratio of 156.5 suggests caution, as the stock may be overvalued in the eyes of investors.
</li>
<li>
Price to Sales (P/S) Ratio: The P/S ratio of 0.27 is lower than the industry average, implying a discounted valuation for OPAL Fuels's stock in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio of 9.46, the company's market valuation exceeds industry averages.
</li>
</ul>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Delving Into the Significance of Insider Transactions</h3>
It's important to note that insider transactions alone should not dictate investment decisions, but they can provide valuable insights.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Unlocking the Meaning of Transaction Codes</h3>
Taking a closer look at transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, meticulously cataloged in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A signifies a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001842279">Check Out The Full List Of OPAL Fuels's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

OPAL

Eye On Growth: Scott Dols V Adds $128K Of OPAL Fuels Stock To Portfolio

It was reported on May 27, that James M Whitehurst, Board Member at United Airlines Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) executed a significant insider sell, according to an SEC filing.
What Happened: Whitehurst opted to sell 1,730 shares of United Airlines Holdings, according to a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000100517/000010051725000114//Archives/edgar/data/100517/000010051725000114/0000100517-25-000114-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday. The transaction's total worth stands at $129,057.
The latest market snapshot at Wednesday morning reveals United Airlines Holdings shares down by 1.3%, trading at $77.16.
<h3>Discovering United Airlines Holdings: A Closer Look</h3>
United Airlines is a major US network carrier with hubs in San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international and long-haul travel than its large US peers.
<h3>United Airlines Holdings's Financial Performance</h3>
Revenue Growth: Over the 3 months period, United Airlines Holdings showcased positive performance, achieving a revenue growth rate of 5.37% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Analyzing Profitability Metrics:
<ul>
<li>
Gross Margin: With a high gross margin of 25.16%, the company demonstrates effective cost control and strong profitability relative to its peers.
</li>
<li>
Earnings per Share (EPS): United Airlines Holdings's EPS is significantly higher than the industry average. The company demonstrates a robust bottom-line performance with a current EPS of 1.18.
</li>
</ul>
Debt Management: United Airlines Holdings's debt-to-equity ratio is notably higher than the industry average. With a ratio of 2.61, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Assessing Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: United Airlines Holdings's P/E ratio of 7.11 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: The P/S ratio of 0.45 is lower than the industry average, implying a discounted valuation for United Airlines Holdings's stock in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 7.04 is below the industry average, indicating that it may be relatively undervalued compared to peers.
</li>
</ul>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Activity Matters in Finance</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision. 
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>A Closer Look at Important Transaction Codes</h3>
Digging into the details of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000100517">Check Out The Full List Of United Airlines Holdings's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Board Member Of United Airlines Holdings Sold $129K In Stock

Michelle Freyre, Board Member at United Airlines Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>), reported an insider sell on May 27, according to a new SEC filing. 
What Happened: According to a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000100517/000010051725000120//Archives/edgar/data/100517/000010051725000120/0000100517-25-000120-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday, Freyre sold 1,730 shares of United Airlines Holdings. The total transaction value is $129,057.
In the Wednesday's morning session, United Airlines Holdings's shares are currently trading at $78.19, experiencing a up of 0.01%.
<h3>All You Need to Know About United Airlines Holdings</h3>
United Airlines is a major US network carrier with hubs in San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international and long-haul travel than its large US peers.
<h3>Understanding the Numbers: United Airlines Holdings's Finances</h3>
Positive Revenue Trend: Examining United Airlines Holdings's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 5.37% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Key Profitability Indicators:
<ul>
<li>
Gross Margin: Achieving a high gross margin of 25.16%, the company performs well in terms of cost management and profitability within its sector.
</li>
<li>
Earnings per Share (EPS): United Airlines Holdings's EPS is significantly higher than the industry average. The company demonstrates a robust bottom-line performance with a current EPS of 1.18.
</li>
</ul>
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.61, caution is advised due to increased financial risk.
Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 7.11 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 0.45, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): At 7.04, United Airlines Holdings's EV/EBITDA ratio reflects a below-par valuation compared to industry averages signalling undervaluation
</li>
</ul>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Navigating the Impact of Insider Transactions on Investments</h3>
While insider transactions should not be the sole basis for making investment decisions, they can play a significant role in an investor's decision-making process.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Navigating the World of Insider Transaction Codes</h3>
In the domain of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their focus to those taking place in the open market, as meticulously outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000100517">Check Out The Full List Of United Airlines Holdings's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Board Member At United Airlines Holdings Sells $129K Of Stock

Press Releases

General

Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival

Comments

Relay Therapeutics

Relay Therapeutics (RLAY) オプション

Relay Therapeutics (NASDAQ:RLAY) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル